Total (n = 23) | SMA type 2 (n = 9) | SMA type 3 (n = 14) | SMA type 2 vs. SMA type 3 | |
---|---|---|---|---|
Age at baseline, years | t(21) = − 2.29;p = 0.0331; d = 0.98 | |||
Mean ± SD Median (Range) | 38.1 ± 11.4 35.0 (18–57) | 31.9 ± 10.8 30.0 (18–54) | 42.1 ± 10.2 42.5 (22–57) | |
Sex, n (%) | p = 0.6692; OR = 2.00 | |||
Female | 10 (43.5) | 3 (33.3) | 7 (50.0) | |
Male | 13 (56.5) | 6 (66.7) | 7 (50.0) | |
SMN2 copy number, n (%) | U = 28.5;Z= − 2.464;p = 0.0283; r = 0.51 | |||
2 | 2 (8.7) | 1 (11.1) | 1 (7.1) | |
3 | 13 (56.5) | 8 (88.9) | 5 (35.7) | |
4 | 8 (34.8) | 0 (0.0) | 8 (57.1) | |
Mobility, n (%) | p = 0.1162; OR = 1.56 | |||
Ambulatory | 5 (21.7) | 0 (0.0) | 5 (37.5) | |
Non-ambulatory | 18 (78.3) | 9 (100.0) | 9 (64.3) | |
Disease duration, years | U = 43.5; Z = − 1.231; p = 0.2243; r = 0.26 | |||
Mean ± SD Median (Range) | 34.6 ± 11.1 32.0 (16–54) | 31.0 ± 11.0 29.3 (16–54) | 36.9 ± 10.8 34.9 (20–49) | |
Education level, years | t(21) = 1.09; p = 0.2581; d = 0.48 | |||
Mean ± SD Median (Range) | 13.5 ± 3.1 13.0 (9–19) | 14.4 ± 3.6 13.0 (9–19) | 12.9 ± 2.7 12.5 (10–18) |